eIF3a的生物学功能研究进展

中国临床药理学与治疗学 ›› 2010, Vol. 15 ›› Issue (2): 219-224.

eIF3a的生物学功能研究进展

徐潇静, 周宏灏, 刘昭前

中南大学临床药理研究所,遗传药理学湖南省重点实验室,长沙 410078, 湖南

收稿日期:2009-11-20 修回日期:2009-12-17 出版日期:2010-02-26 发布日期:2020-09-18
通讯作者: 刘昭前,男,博士,教授,博士生导师,研究方向:遗传药理学和临床药理学。Tel: 0731-84805380 E-mail: liuzhaoqian63@126.com
作者简介:徐潇静,女,硕士研究生,研究方向:临床药理学与遗传药理学。Tel: 0731-84805380 E-mail: Selina33@163.com
基金资助:
国家自然科学基金项目(30873089);湖南省自然科学基金重点项目(08JJ3058);湖南省“芙蓉学者计划”特聘教授基金(湘教通[2006]312号)

Recent research progress of eIF3 in biological function

XU Xiao-jing, ZHOU Hong-hao, LIU Zhao-qian

Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha 410078, Hunan, China

Received:2009-11-20 Revised:2009-12-17 Online:2010-02-26 Published:2020-09-18

摘要/Abstract

摘要： eIF3a是真核翻译起始因子eIF3中最大的亚单位。许多研究表明,在酵母细胞和哺乳动物细胞中,eIF3a都参与了mRNA翻译的起始过程,并在蛋白质翻译起始过程中起重要调控作用。同时,eIF3a参与了细胞周期的调控,它与细胞的生长和分化存在着重要联系。最近的研究发现,eIF3a与肿瘤的发生、发展、预后和化疗疗效密切相关,且eIF3a基因多态性与恶性肿瘤的易感性也有一定相关性。本文对近年来eIF3a的生物学功能研究进展进行综述。

关键词: eIF3a, 翻译, 细胞周期, 分化增殖, 肿瘤

Abstract: eIF3a is the largest subunit of mammalian eukaryotic initiation factor 3 (eIF3). It has been shown by many research that eIF3a plays an essential role in regulating the initiation of mRNA translation and protein translation in mammalian cells as well as yeast cells.Additionally, eIF3a involves in cell cycle regulation, which also influents cell proliferation and differentiation greatly. There is a close relationship between eIF3a and tumor progression, development, prognosis and chemotherapeutic efficacy, moreover the genetic polymorphisms of eIF3a associates with susceptibility of carcinoma. This review summarizes the research progress of eIF3a biological functions in recent years.

Key words: eIF3a, Translation, Cell cycle, Proliferation and differentiation, Carcinoma

中图分类号:

R965.2

徐潇静, 周宏灏, 刘昭前. eIF3a的生物学功能研究进展[J]. 中国临床药理学与治疗学, 2010, 15(2): 219-224.

XU Xiao-jing, ZHOU Hong-hao, LIU Zhao-qian. Recent research progress of eIF3 in biological function[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 219-224.

参考文献

[1] Browning KS, Gallie DR, Hershey JW, et al. Unified nomenclature for the subunits of eukaryotic initiation factors 3[J]. Trends Biochem Sci, 2001, 26(5):284.
[2] Mamiko M, Nahum S, Shigeyuki Y, et al. Reconstitution reveals the functional core of mammalian eIF3[J]. EMBO J, 2007, 26(14):3373-3383.
[3] Hershey JWB, Merrick WC. Pathway and mechanism of initiation of protein synthesis. In: Soneneberg N, Hershey JWB, Mathews MB, editors. Translational control of gene expression[C]. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 2000: 33-88.
[4] Zhou C, Alrslan F, Wee S, et al. PCI proteins eIF3e and eIF3m define distinct translation initiation factors 3 complexes[J]. BMC Biol, 2005, 3(1):14.
[5] Alan G. Hinnebusch. eIF3: a versatile scaffold for translation initiation complexes[J]. Bio Sci, 2006, 31(10):553-562.
[6] Dong Z, Zhang JT. Initiation factor eIF3 and regulation of mRNA translation, cell growth and cancer[J]. Oncology, 2006, 59(3):169-180.
[7] Valasek L, Phan L, Anderson J, et al. Complex formation by all five homologues of mammalian translation initiation factors 3 subunits from yeast Saccharomyces cerevisiae[J]. J Biol Chem, 2002, 21(21):5886-5898.
[8] Valasek L, Mathew AA, Shin BS, et al. The yeast eIF3 subunits TIF32/a, NIP1/c, and eIF5 make critical connections with the 40S ribosome in vivo[J]. Gene Dev, 2003, 17(6):786-799.
[9] Barbara K, Surinder K, Efstratios K, et al. Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase and ribosomal protein S6K-mediate signal[J]. Mol Cell Biol, 2009, 29(3):2865-2875.
[10] Pestova TV, Kolupaeva VG. The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection[J]. Genes Dev, 2002, 16(22):2906-2922.
[11] Chaudhuri J, Chakrabarti A, Maitra U. Biochemical characterization of mammalian translation initiation factor 3[J]. J Biol Chem, 1997, 272(49):30975-30983.
[12] Dong ZZ, Liu LH, Han BG, et al. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth[J]. Oncogene, 2004, 23(21):3790-3801.
[13] Dong ZZ, Zhang JT. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression[J]. Mol Biol Cell,2003, 14(9):3942-3951.
[14] Pincheira R, Chen Q, Huang Z, et al. Two subcelluar localizations of eIF3 P170 and its interaction with membrane-bound micro-filaments: implication for alternative function of P170[J]. Eur J Cell Biol, 2001, 80(6):410-418.
[15] Chudinova EM, Ivanov PA, Nadezhdina ES. Large subunit of translation initiation factor-3P170 contains potentially functional nuclear localization signals[J]. Mol Biol (Mosk), 2004, 38(4):684-691.
[16] Asp E, Nilsson D, Sunnerhagen P. Fisson yeast mitogen-activated protein kinase Sty1 interacts with translation initiation factors[J]. Eukaryotic Cell, 2008, 7(2):328-338.
[17] Miguel RP, Serrano P, Saiz M, et al. Foot-and-mouth disease virus infection induce proteolytic cleavage of PTB, eIF3a,b, and PABP RNA-binding proteins[J]. Virology, 2007, 364(2):466-474.
[18] Nakai Y, Shiratsuchi A, Manaka J, et al. Externalization and recognition by macrophage of large subunit of eukaryotic translation initiation factor 3 in apoptosis cells[J]. Exp Cell Res, 2005, 309(1):137-148.
[19] Kovarik P, Hasek J, Valasek L, et al. RPG1: an essential gene of Saccharomyces cerevisae encoding a 110000 protein required for passage through the G₁ phase[J]. Curr Genet, 1998, 33(2):100-109.
[20] Dong ZZ, Liu ZQ, Ping C, et al. Role of eIF3a in regulating cell cycle progression[J]. Exp Cell Res, 2009, 315(11):1889-1894.
[21] Liu Z, Dong Z, Yang Z, et al. Role of eIF3a (eIF3 p170) intestinal cell differentiation and its association with early development[J]. Differentiation, 2007, 75(7):652-661.
[22] Yingdee U, Yi H, Ergin B, et al. MILI, a pirna binding protein, is required for germline stem cell self-renewal and appears to positively regulate translation[J]. J Biol Chem, 2008, 284(10):6507-6519.
[23] Benedetti D, Graff JR. eIF4E expression and its role in malignancies and metastases[J]. Oncogene, 2004, 23(18):3189-199.
[24] Fukuchi ST, Ishii I, Kashiwagi K, et al. Malignant transformation by overproduction of translation initiation factor eIF4G[J]. Cancer, 1997, 57(22):5041-5044.
[25] Zhang LL, Pan XY, Hershey JWB. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells[J]. J Biol Chem, 2007, 282(8):5790-5800.
[26] Bachmann F, Banziger R, Burger MM. Cloning of a novel protein over-expressed in human mammary carcinoma[J]. Cancer Res, 1997, 57(5):988-994.
[27] 韩丽芳,刘昭前.eIF3亚家族与恶性肿瘤发生的关系[J]. 中国临床临床药理学与治疗, 2008,13(10):1195-1200.
[28] Chen G, Burger MM. p150 expression and its prognostic value in squamous-cell carcinoma of esophagus[J]. Int J Cancer, 1999, 84(2):95-100.
[29] Chen G, Burger MM. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation[J]. Int J Cancer, 2004, 112(3):393-398.
[30] Pincheria R, Chen Q, Zhang JT, et al. Identification of a 170-KDa protein over-expressed in lung cancer[J]. Br J Cancer, 2001, 84(11):1520-1527.
[31] 沈杰,李慧华,张建亭,等. eIF3S10在肺癌组织中的表达及与化疗反应的关系[J]. 国际病理科学与临床杂志, 2006, 26(5):369-371.
[32] Olson JE, Wang X, Goode EL, et al. Variation in genes required for normal mitosis and risk of breast cancer[J]. Breast Cancer Res Treat, 2009, 19(2): 423-430.